Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank82
3Y CAGR+19.2%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+19.2%/yr
Annual compound
Percentile
P82
Within normal range
vs 3Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$11.28M-40.2%
2024$18.86M+123.2%
2023$8.45M+26.9%
2022$6.66M-40.5%
2021$11.20M+110.7%
2020$-104.36M-127.2%
2019$383.33M+27114.2%
2018$-1.42M-171.0%
2017$2.00M-63.0%
2016$5.39M-